Revenue and margins have swung sharply, with operating margin moving from -49.2% in 2026Q2 to +18.3% in 2027Q1, but this trajectory appears driven by lumpy order volume rather than a steady compounding trend.
Aehr Test Systems (AEHR) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | May'26 | May'25 | May'24 | May'23 | May'22 | May'21 | May'20 | May'19 | May'18 | May'17 | May'16 | May'15 | May'14 | May'13 | May'12 | May'11 | May'10 | May'09 | May'08 | May'07 | May'06 | May'05 | May'04 | May'03 | May'02 | May'01 | May'00 | May'99 | May'98 | May'97 |
|---|
| Sales/Revenue | 72.95M | 50M | 58.97M | 66.22M | 64.96M | 50.83M | 16.6M | 22.29M | 21.06M | 29.55M | 18.9M | 14.5M | 10.02M | 19.68M | 16.49M | 15.52M | 13.74M | 11.67M | 21.41M | 39.04M | 27.35M | 23.8M | 16.08M | 15.8M | 15.09M | 12.57M | 31.04M | 24.5M | 18.15M | 40.8M | 42M |
| Revenue Growth % | 28.4% | -15.21% | -10.95% | 1.93% | 27.8% | 206.2% | -25.53% | 5.87% | -28.76% | 56.39% | 30.32% | 44.75% | -49.11% | 19.38% | 6.23% | 12.99% | 17.67% | -45.47% | -45.17% | 42.74% | 14.92% | 48.02% | 1.77% | 4.69% | 20.08% | -59.51% | 26.66% | 35.04% | -55.53% | -2.85% | - |
| Cost of Goods Sold | 43.36M | 32.35M | 35.03M | 33.67M | 32.22M | 27.16M | 10.57M | 13.92M | 13.45M | 17.17M | 12.12M | 9.36M | 6.18M | 9.46M | 9.71M | 9.31M | 8.22M | 5.57M | 19.82M | 19.07M | 13.44M | 13.16M | 11.82M | 10.09M | 9.35M | 6.49M | 17.92M | 17.27M | 12.2M | 24.36M | 25.1M |
| COGS % of Revenue | - | 64.7% | 59.41% | 50.85% | 49.59% | 53.44% | 63.66% | 62.45% | 63.9% | 58.09% | 64.12% | 64.52% | 61.69% | 48.07% | 58.9% | 60.01% | 59.87% | 47.72% | 92.6% | 48.85% | 49.13% | 55.31% | 73.49% | 63.87% | 61.98% | 51.62% | 57.74% | 70.46% | 67.24% | 59.7% | 59.76% |
| Gross Profit | 29.59M | 17.65M | 23.93M | 32.54M | 32.75M | 23.66M | 6.03M | 8.37M | 7.6M | 12.39M | 6.78M | 5.14M | 3.84M | 10.22M | 6.78M | 6.21M | 5.51M | 6.1M | 1.18M | 19.97M | 13.91M | 10.64M | 4.26M | 5.71M | 5.74M | 6.08M | 13.12M | 7.24M | 5.95M | 16.45M | 16.9M |
| Gross Margin % | 40.57% | 35.3% | 40.59% | 49.15% | 50.41% | 46.56% | 36.34% | 37.55% | 36.1% | 41.91% | 35.88% | 35.48% | 38.31% | 51.93% | 41.1% | 39.99% | 40.13% | 52.28% | 5.53% | 51.15% | 50.87% | 44.69% | 26.51% | 36.13% | 38.02% | 48.38% | 42.26% | 29.54% | 32.76% | 40.3% | 40.24% |
| Gross Profit Growth % | - | -26.25% | -26.46% | -0.62% | 38.37% | 292.32% | -27.94% | 10.12% | -38.62% | 82.68% | 31.78% | 34.05% | -62.45% | 50.86% | 9.17% | 12.61% | -9.68% | 415.46% | -94.07% | 43.53% | 30.81% | 149.5% | -25.32% | -0.52% | -5.63% | -53.64% | 81.21% | 21.75% | -63.85% | -2.69% | - |
| Operating Expenses | 33.63M | 31.8M | 28.25M | 22.46M | 19.37M | 15.87M | 10.21M | 10.92M | 11.88M | 11.47M | 11.71M | 11.3M | 10.53M | 9.72M | 10.08M | 10.71M | 10.53M | 10.85M | 26.39M | 14.16M | 12.86M | 10.18M | 9.24M | 10.22M | 10.46M | 10.58M | 11.64M | 12.43M | 10.58M | 12.25M | 13.2M |
| OpEx % of Revenue | - | 63.6% | 47.9% | 33.93% | 29.82% | 31.21% | 61.53% | 48.97% | 56.41% | 38.81% | 61.96% | 77.92% | 105.13% | 49.41% | 61.15% | 69.03% | 76.66% | 92.96% | 123.25% | 36.26% | 47.03% | 42.78% | 57.45% | 64.66% | 69.32% | 84.21% | 37.51% | 50.73% | 58.29% | 30.01% | 31.43% |
| Selling, General & Admin | 19.92M | 19.16M | 17.78M | 13.75M | 12.24M | 10.05M | 6.56M | 7.53M | 7.72M | 7.29M | 7.05M | 6.97M | 6.47M | 6.32M | 6.87M | 6.53M | 5.96M | 6.09M | 20.62M | 7.66M | 6.54M | 5.84M | 5.21M | 5.57M | 5.92M | 6.55M | 7.26M | 7.93M | 6.89M | 8.62M | 8.9M |
| SG&A % of Revenue | - | 38.32% | 30.16% | 20.76% | 18.84% | 19.77% | 39.53% | 33.78% | 36.68% | 24.67% | 37.32% | 48.1% | 64.58% | 32.12% | 41.68% | 42.05% | 43.42% | 52.2% | 96.34% | 19.61% | 23.9% | 24.55% | 32.43% | 35.27% | 39.22% | 52.09% | 23.4% | 32.36% | 37.98% | 21.12% | 21.19% |
| Research & Development | 13.93M | 12.63M | 10.46M | 8.72M | 7.13M | 5.82M | 3.65M | 3.39M | 4.15M | 4.18M | 4.66M | 4.32M | 4.06M | 3.4M | 3.21M | 4.19M | 4.57M | 4.76M | 5.76M | 6.5M | 6.32M | 4.34M | 4.02M | 4.64M | 4.54M | 4.04M | 4.38M | 4.5M | 3.69M | 3.63M | 3.7M |
| R&D % of Revenue | - | 25.27% | 17.74% | 13.17% | 10.98% | 11.45% | 22% | 15.19% | 19.72% | 14.15% | 24.64% | 29.82% | 40.55% | 17.28% | 19.47% | 26.98% | 33.25% | 40.76% | 26.92% | 16.65% | 23.12% | 18.23% | 25.02% | 29.4% | 30.1% | 32.11% | 14.12% | 18.37% | 20.31% | 8.89% | 8.81% |
| Other Operating Expenses | -213K | 6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 600K |
| Operating Income | -4.04M | -14.15M | -4.31M | 10.08M | 13.38M | 7.8M | -4.18M | -2.54M | -4.28M | 915K | -4.93M | -6.15M | -6.69M | 497K | -3.31M | -4.51M | -5.02M | -4.75M | -24.8M | 5.81M | 1.05M | 455K | -4.97M | -4.51M | -4.72M | -4.5M | 1.47M | -5.19M | -4.63M | 4.2M | 3.7M |
| Operating Margin % | -5.54% | -28.3% | -7.31% | 15.22% | 20.59% | 15.35% | -25.19% | -11.42% | -20.3% | 3.1% | -26.08% | -42.44% | -66.82% | 2.52% | -20.06% | -29.04% | -36.54% | -40.68% | -115.85% | 14.88% | 3.84% | 1.91% | -30.94% | -28.54% | -31.3% | -35.83% | 4.74% | -21.19% | -25.53% | 10.29% | 8.81% |
| Operating Income Growth % | - | -228.05% | -142.8% | -24.65% | 71.47% | 286.51% | -64.32% | 40.47% | -567.21% | 118.56% | 19.91% | 8.07% | -1446.88% | 115.03% | 26.63% | 10.2% | -5.69% | 80.85% | -526.79% | 452.9% | 130.99% | 109.15% | -10.33% | 4.55% | -4.91% | -405.91% | 128.35% | -12.11% | -210.31% | 13.49% | - |
| EBITDA | -4.26M | -11.74M | -925K | 11.44M | 13.82M | 8.11M | -3.87M | -2.16M | -3.84M | 1.33M | -4.66M | -5.95M | -6.56M | 638K | -2.98M | -4.02M | -4.45M | -4.06M | -24.16M | 6.29M | 1.37M | 795K | -4.65M | -4.13M | -4.14M | -3.84M | 2.12M | -4.49M | -4.18M | 4.68M | 4.3M |
| EBITDA Margin % | -5.84% | -23.47% | -1.57% | 17.28% | 21.28% | 15.95% | -23.33% | -9.69% | -18.26% | 4.51% | -24.65% | -41.04% | -65.47% | 3.24% | -18.1% | -25.87% | -32.37% | -34.77% | -112.85% | 16.1% | 5.02% | 3.34% | -28.93% | -26.11% | -27.45% | -30.56% | 6.84% | -18.32% | -23.03% | 11.46% | 10.24% |
| EBITDA Growth % | 19.59% | -1168.76% | -108.09% | -17.24% | 70.53% | 309.38% | -79.18% | 43.78% | -388.59% | 128.6% | 21.73% | 9.27% | -1128.06% | 121.37% | 25.67% | 9.67% | -9.53% | 83.2% | -484.36% | 357.42% | 72.83% | 117.09% | -12.78% | 0.41% | -7.84% | -280.92% | 147.28% | -7.44% | -189.33% | 8.79% | - |
| D&A (Non-Cash Add-back) | -215K | 0 | 3.39M | 1.36M | 450K | 307K | 310K | 384K | 431K | 417K | 271K | 203K | 135K | 141K | 322K | 491K | 573K | 690K | 644K | 474K | 323K | 340K | 323K | 384K | 582K | 662K | 651K | 703K | 453K | 479K | 600K |
| EBIT | -962K | -11.74M | -4.29M | 12.46M | 14.62M | 9.54M | -2.16M | -2.77M | -4.96M | 854K | -4.95M | -6.17M | -6.48M | 433K | -3.34M | -3.4M | -3.42M | -620K | -25.06M | 5.97M | 2.5M | 789K | -4.73M | -4.51M | -4.72M | -4.5M | 1.47M | -5.19M | -4.63M | 4.2M | 3.68M |
| Net Interest Income | 2.08M | 1.36M | 1.4M | 2.39M | 1.25M | 13K | -46K | 10K | -252K | -399K | -678K | -605K | -130K | -26K | -49K | -4K | 3K | 5K | 142K | 231K | 1.43M | 374K | 155K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 2.08M | 1.36M | 1.4M | 2.39M | 1.25M | 13K | 0 | 10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3K | 5K | 142K | 231K | 1.43M | 374K | 155K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 46K | 0 | 252K | 399K | 678K | 605K | 130K | 26K | 49K | 4K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.06M | 2.41M | 22K | 2.38M | 1.24M | 1.74M | 1.98M | -221K | -933K | -460K | -699K | -621K | 81K | -90K | -82K | 1.1M | 1.6M | 4.13M | -255K | 160K | 1.45M | 334K | 241K | 626K | 106K | 477K | 1.06M | 1.47M | 1.63M | 540K | -1.14M |
| Pretax Income | -1.98M | -11.74M | -4.29M | 12.46M | 14.62M | 9.54M | -2.2M | -2.77M | -5.21M | 455K | -5.63M | -6.78M | -6.61M | 407K | -3.39M | -3.4M | -3.42M | -620K | -25.06M | 5.97M | 2.5M | 789K | -4.73M | -3.88M | -4.62M | -4.03M | 2.53M | -3.72M | -3.01M | 4.74M | 2.6M |
| Pretax Margin % | -2.71% | -23.47% | -7.28% | 18.81% | 22.5% | 18.77% | -13.28% | -12.41% | -24.73% | 1.54% | -29.78% | -46.72% | -66.01% | 2.07% | -20.55% | -21.93% | -24.91% | -5.31% | -117.05% | 15.29% | 9.15% | 3.31% | -29.44% | -24.58% | -30.6% | -32.03% | 8.16% | -15.18% | -16.57% | 11.61% | 6.19% |
| Income Tax | -4.12M | -4.61M | -381K | -20.7M | 60K | 91K | -177K | 36K | 27K | -73K | 25K | 10K | 34K | -15K | 30K | -15K | -49K | -139K | 4.92M | -4.6M | 75K | -21K | 136K | 76K | -74K | 1.24M | 1.05M | -1.12M | -677K | 2.33M | -700K |
| Effective Tax Rate % | 208.08% | 39.28% | 8.88% | -166.14% | 0.41% | 0.95% | 8.03% | -1.3% | -0.52% | -16.04% | -0.44% | -0.15% | -0.51% | -3.69% | -0.89% | 0.44% | 1.43% | 22.42% | -19.62% | -77.07% | 3% | -2.66% | -2.87% | -1.96% | 1.6% | -30.82% | 41.28% | 29.99% | 22.51% | 49.25% | -26.92% |
| Net Income | 2.14M | -7.13M | -3.91M | 33.16M | 14.56M | 9.45M | -2.03M | -2.8M | -5.24M | 528K | -5.65M | -6.79M | -6.65M | 422K | -3.42M | -3.39M | -3.37M | -481K | -29.97M | 10.57M | 2.43M | 810K | -4.87M | -3.96M | -4.54M | -5.27M | -141K | -2.6M | -2.33M | 2.4M | 3.3M |
| Net Margin % | 2.93% | -14.25% | -6.63% | 50.07% | 22.41% | 18.59% | -12.21% | -12.57% | -24.86% | 1.79% | -29.91% | -46.79% | -66.35% | 2.14% | -20.74% | -21.83% | -24.55% | -4.12% | -140.01% | 27.08% | 8.88% | 3.4% | -30.29% | -25.06% | -30.11% | -41.91% | -0.45% | -10.63% | -12.84% | 5.89% | 7.86% |
| Net Income Growth % | 132.15% | -82.25% | -111.79% | 127.77% | 54.04% | 566.21% | 27.66% | 46.48% | -1091.48% | 109.34% | 16.68% | -2.08% | -1675.12% | 112.34% | -0.89% | -0.47% | -601.25% | 98.4% | -383.47% | 335.46% | 199.75% | 116.63% | -23.01% | 12.87% | 13.73% | -3635.46% | 94.59% | -11.8% | -196.88% | -27.12% | - |
| Net Income (Continuing) | 2.14M | -7.13M | -3.91M | 33.16M | 14.56M | 9.45M | -2.03M | -2.8M | -5.24M | 528K | -5.65M | -6.79M | -6.65M | 422K | -3.42M | -3.39M | -3.37M | -481K | -29.97M | 10.57M | 2.43M | 810K | -4.87M | -3.96M | -4.54M | -5.27M | 1.49M | -2.6M | -2.33M | 2.4M | 3.31M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -21K | -19K | -20K | -19K | -20K | -18K | -21K | -20K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.06 | -0.23 | -0.13 | 1.12 | 0.50 | 0.34 | -0.09 | -0.12 | -0.23 | 0.02 | -0.35 | -0.52 | -0.55 | 0.04 | -0.36 | -0.38 | -0.38 | -0.06 | -3.55 | 1.24 | 0.30 | 0.11 | -0.66 | -0.55 | -0.63 | -0.74 | -0.02 | -0.38 | -0.34 | 0.36 | 0.74 |
| EPS Growth % | 122.23% | -76.92% | -111.61% | 124% | 47.06% | 493.52% | 28% | 48.67% | -1269% | 105.71% | 32.69% | 5.45% | -1475% | 111.11% | 5.26% | 0% | -533.33% | 98.31% | -386.29% | 313.33% | 172.73% | 116.67% | -20% | 12.7% | 14.86% | -3675.51% | 94.84% | -11.76% | -194.44% | -51.35% | - |
| EPS (Basic) | - | -0.23 | -0.13 | 1.15 | 0.52 | 0.36 | -0.09 | -0.12 | -0.23 | 0.02 | -0.35 | -0.52 | -0.55 | 0.04 | -0.36 | -0.38 | -0.38 | -0.06 | -3.55 | 1.32 | 0.31 | 0.11 | -0.66 | -0.55 | -0.63 | -0.74 | -0.02 | -0.38 | -0.34 | 0.38 | 0.77 |
| Diluted Shares Outstanding | 33.52M | 30.67M | 29.58M | 29.62M | 29.21M | 27.77M | 23.46M | 22.88M | 22.39M | 22.78M | 16.27M | 13.09M | 12.05M | 11.89M | 9.55M | 9.02M | 8.78M | 8.56M | 8.44M | 8.51M | 8.22M | 7.61M | 7.42M | 7.25M | 7.16M | 7.15M | 7.18M | 6.81M | 6.85M | 6.76M | 4.5M |
| Basic Shares Outstanding | 32.62M | 30.67M | 29.58M | 28.82M | 27.79M | 26.01M | 23.46M | 22.88M | 22.39M | 21.73M | 16.27M | 13.09M | 12.05M | 10.88M | 9.55M | 9.02M | 8.78M | 8.56M | 8.44M | 8.01M | 7.75M | 7.51M | 7.42M | 7.25M | 7.16M | 7.15M | 7.07M | 6.81M | 6.85M | 6.33M | 4.3M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quick answers to the most common questions about buying AEHR stock.
For fiscal year 2026, Aehr Test Systems (AEHR) reported total revenue of $50.0M. This represents a 19.1% increase compared to $42.0M in 1997.
Aehr Test Systems (AEHR) reported a net loss of $7.1M for the fiscal year ending 2026.
Aehr Test Systems (AEHR) reported an operating income of $-14.1M, resulting in an operating profit margin of -28.3%. This margin reflects the operational efficiency of the business before interest and taxes.
Aehr Test Systems (AEHR) generated $17.7M in gross profit for the year, representing a gross profit margin of 35.3%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Volatile demand and losses
Metrics are mathematically derived from official filings.
Revenue Rebounds Sharply from Trough
According to the reported quarterly income statements, AEHR revenue rose from $9.9M in 2026Q2 to $33.0M in 2027Q1, a sequential rebound that suggests lumpy, order-driven demand rather than a steady compounding trend across the ten-quarter window.
The revenue series swings widely between roughly $10M and $33M, which points to a business dependent on episodic capital equipment orders from semiconductor test customers. The 2027Q1 spike is the strongest quarter in the dataset, but a single quarter of elevated revenue does not by itself establish durability, and investors should monitor whether subsequent quarters hold near this level. Year-over-year growth figures are volatile in both directions, reinforcing that the trajectory is cyclical rather than structurally accelerating.
Gross Margin Recovers Toward Historical Highs
As reflected in reported figures, AEHR gross margin climbed from 25.7% in 2026Q2 to 47.5% in 2027Q1, approaching the 50-54% levels seen in 2024Q4 and 2025Q1, which suggests volume leverage on fixed manufacturing costs.
The margin swing tracks revenue closely, indicating that a large share of cost of revenue behaves as fixed overhead rather than variable input cost. Recovery toward prior peak margins is encouraging, yet the magnitude of the swing implies limited pricing power that would otherwise cushion weak-volume quarters. Investors should treat the 2027Q1 margin as contingent on sustained shipment volume rather than as a new structural baseline.
Operating Losses Narrow Only on Volume
Based on the reported operating figures, AEHR operating margin moved from -49.2% in 2026Q2 to +18.3% in 2027Q1, showing operating income scaling faster than revenue only when sales volume rose meaningfully.
Operating expenses of roughly $7-10M per quarter, combining R&D and SG&A, remained relatively flat across the period, so the profitability swing is largely a function of revenue absorbing a fixed cost base. This creates high operating leverage in both directions, meaning modest revenue shortfalls can return the company to deep losses. The cost base has not visibly shrunk during the downturn, which warrants further investigation into whether spending discipline is maintained when volumes weaken.
Net Income Inflated by 2024 Gain
According to the reported income statement, AEHR posted $23.9M of net income in 2024Q4 on only $2.5M of operating income, a gap that suggests a large non-operating or tax-related item rather than core operating performance.
The disconnect between operating income and net income in 2024Q4 is too large to attribute to ordinary operations, implying non-operating gains or tax benefits that should be examined in the filing footnotes. Reported EPS in that quarter therefore overstates the underlying earning power of the business. Excluding this period, net income has been negative in most remaining quarters, so earnings quality should be assessed on operating results instead.
Recovery May Prove Another Cyclical Peak
Based on the reported quarterly figures, AEHR's sharp 2027Q1 rebound follows multiple quarters of losses, and a bear case would argue it reflects a temporary order surge rather than a sustained demand recovery.
Operating losses persisted across most of the ten quarters, and the single profitable quarter of 2027Q1 is the only recent evidence of a return to profitability. A short-seller view would emphasize that the margin recovery depends on one quarter of elevated revenue, and that a reversion to the $10M revenue level would restore losses near -40% operating margin. Investors should monitor whether order flow sustains revenue above the $20M range before extrapolating the recent improvement.